P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.42 CNY -1.04% Market Closed
Market Cap: 4.3B CNY

Pulike Biological Engineering Inc's latest stock split occurred on May 31, 2016

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, Pulike Biological Engineering Inc traded at 44.16 per share. Afterward, the share price was about 21.4548.

The adjusted shares began trading on May 31, 2016. This was the only stock split in Pulike Biological Engineering Inc's history.

Last Splits:
May 31, 2016
2-for-1
Pre-Split Price
20.1503 44.16
Post-Split Price
21.4548
Before
After
Last Splits:
May 31, 2016
2-for-1

Pulike Biological Engineering Inc
Stock Splits History

Pulike Biological Engineering Inc Stock Splits Timeline
May 31, 2016
May 31, 2016
Split 2-for-1
x2
Pre-Split Price
20.1503 44.16
Post-Split Price
21.4548
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 28, 2025
Yellow Hat Ltd
OTC:YLLWF
2-for-1
x2
16.93 8.3482 USD 8.465 8.465 USD
Mar 25, 2025
CMC Metals Ltd
XTSX:CMB
1-for-10
/10
0.02 0.2 CAD 0.25 0.25 CAD
Mar 25, 2025
Rent.com.au Ltd
ASX:RNT
63-for-62
x1.0161290322581
0.021 0.0207 AUD 0.018 0.018 AUD
Mar 25, 2025
U
US Critical Metals Corp
OTC:USCMF
1-for-2
/2
0.06 0.15 USD 0.1127 0.1127 USD
Mar 25, 2025
CMC Metals Ltd
F:ZM5P
1-for-10
/10
0.0038 0.038 EUR 0.009 0.009 EUR
Load More

Pulike Biological Engineering Inc
Glance View

Market Cap
4.3B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
17.35 CNY
Undervaluation 28%
Intrinsic Value
Price
P
Back to Top